ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
London-based firm will develop weight-loss molecules licensed from a Chinese company
The 2025 ACS president will focus on supporting industrial chemistry and making membership more diverse and global
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials
As we look to the future, C&EN will be making changes to its print and digital delivery
Non-alcoholic adult drinks get good using chemistry
A new use for the tonnes of triphenylphosphine oxide discarded each year?
Up to 10 of the 19 faculty positions are slated to be eliminated, unless alternative cost-saving measures are found
Neurodivergent scientists say STEM isn’t built for them, despite the contributions they bring
This high school chemistry instructor crafts diverse crossword puzzles in between teaching and competing on game shows
If implemented, the move would cement Chinese dominance over the key battery material
Donald J. Trump’s imminent return to the US presidency isn’t the only wild card for chemistry business and policy this year. Here’s what C&EN’s editors expect in the months ahead.
Largest proteomic study to date launched by consortium of 14 drug companies
Evidence from ice cores shows widespread lead pollution that may have caused IQ decline throughout the empire
Light-powered microelectronics enable high-throughput experimentation